Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.
Over the last 12 months, insiders at Vincerx Pharma, Inc. have bought $50,813 and sold $0 worth of Vincerx Pharma, Inc. stock.
On average, over the past 5 years, insiders at Vincerx Pharma, Inc. have bought $355,970 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hamdy Ahmed MD (See Remarks) — $21,161. Izumi Raquel E. (See Remarks) — $14,934. Seelenberger Alexander A. (See Remarks) — $9,968.
The last purchase of 10,500 shares for transaction amount of $9,968 was made by Seelenberger Alexander A. (See Remarks) on 2023‑08‑11.
2023-08-11 | Seelenberger Alexander A. | See Remarks | 10,500 0.0503% | $0.95 | $9,968 | -2.94% | ||
2023-08-10 | THOMAS TOM C | See Remarks | 5,000 0.0241% | $0.95 | $4,750 | -4.91% | ||
2023-08-10 | Hamdy Ahmed MD | See Remarks | 5,400 0.0263% | $0.96 | $5,167 | -4.91% | ||
2023-08-10 | Izumi Raquel E. | See Remarks | 3,440 0.0163% | $0.93 | $3,199 | -4.91% | ||
2023-08-09 | Hamdy Ahmed MD | See Remarks | 16,900 0.0827% | $0.95 | $15,994 | -2.82% | ||
2023-08-09 | Izumi Raquel E. | See Remarks | 13,036 0.0607% | $0.90 | $11,735 | -2.82% | ||
2022-12-14 | Hamdy Ahmed MD | Chief Executive Officer | 35,280 0.1661% | $0.87 | $30,538 | +15.52% | ||
2022-12-14 | Izumi Raquel E. | See Remarks | 28,738 0.1383% | $0.88 | $25,427 | +15.52% | ||
2022-12-14 | THOMAS TOM C | See Remarks | 7,000 0.0316% | $0.83 | $5,810 | +15.52% | ||
2022-08-24 | LOWE CHRISTOPHER P. | 18,400 0.0871% | $1.65 | $30,299 | -33.33% | |||
2022-06-27 | Izumi Raquel E. | See Remarks | 40,000 0.193% | $1.41 | $56,312 | -12.95% | ||
2022-06-23 | Hamdy Ahmed MD | Chief Executive Officer | 24,200 0.1121% | $1.41 | $34,137 | -16.55% | ||
2022-06-09 | Bushnell Laura I. | 15,000 0.0725% | $1.91 | $28,625 | -35.64% | |||
2021-12-23 | Hwang Sooin | Chief Business Officer | 3,000 0.0144% | $10.00 | $30,000 | -84.35% | ||
2021-12-22 | Hamdy Ahmed MD | Chief Executive Officer | 6,450 0.0301% | $10.02 | $64,650 | -84.71% | ||
2021-12-22 | Seelenberger Alexander A. | Chief Financial Officer | 2,417 0.0116% | $10.34 | $24,988 | -84.71% | ||
2021-12-22 | Bushnell Laura I. | director | 2,402 0.0117% | $10.48 | $25,173 | -84.71% | ||
2021-12-22 | THOMAS TOM C | See Remarks | 1,000 0.0048% | $10.23 | $10,230 | -84.71% | ||
2021-08-04 | Izumi Raquel E. | See Remarks | 1,000 0.0058% | $11.96 | $11,960 | -41.48% | ||
2021-06-30 | Hwang Sooin | Chief Business Officer | 500 0.0028% | $12.66 | $6,330 | -24.44% |
THOMAS TOM C | See Remarks | 219935 1.0287% | $0.59 | 4 | 0 | <0.0001% |
Hamdy Ahmed MD | See Remarks | 96060 0.4493% | $0.59 | 6 | 0 | <0.0001% |
Izumi Raquel E. | See Remarks | 85214 0.3986% | $0.59 | 5 | 0 | <0.0001% |
Seelenberger Alexander A. | See Remarks | 30280 0.1416% | $0.59 | 3 | 0 | <0.0001% |
Hwang Sooin | Chief Business Officer | 390491 1.8264% | $0.59 | 2 | 0 | <0.0001% |
LOWE CHRISTOPHER P. | 28400 0.1328% | $0.59 | 3 | 0 | <0.0001% | |
McDonald Andrew I | director | 20000 0.0935% | $0.59 | 1 | 0 | <0.0001% |
Bushnell Laura I. | 19202 0.0898% | $0.59 | 3 | 0 | <0.0001% | |
Lee John H. | director | 799 0.0037% | $0.59 | 1 | 0 | <0.0001% |
Sage Rhino Capital LLC | $8.62M | 5.77 | 1.7M | 0% | +$0 | 2.15 | |
Octagon Capital Advisors LP | $5.06M | 3.39 | 1M | New | +$5.06M | 0.66 | |
Point72 Asset Management | $4.83M | 3.23 | 954,827 | +176.9% | +$3.09M | 0.01 | |
ROCK SPRINGS CAPITAL MANAGEMENT, LP | $4.51M | 3.02 | 891,719 | 0% | +$0 | 0.12 | |
Bank of America | $3.55M | 2.38 | 701,423 | -35.23% | -$1.93M | <0.0001 | |
The Vanguard Group | $3.37M | 2.26 | 666,995 | +29.91% | +$777,089.34 | <0.0001 | |
Goldman Sachs | $3.2M | 2.14 | 631,490 | -63.06% | -$5.46M | <0.01 | |
Kingdon Capital Management | $1.95M | 1.3 | 385,000 | 0% | +$0 | 0.26 | |
ExodusPoint Capital Management, LP | $1.6M | 1.07 | 316,642 | -2.31% | -$37,828.70 | 0.02 | |
Geode Capital Management | $923,668.00 | 0.62 | 182,483 | +18.47% | +$144,014.52 | <0.0001 | |
Citadel Advisors LLC | $901,894.00 | 0.6 | 178,240 | -9.69% | -$96,742.10 | <0.01 | |
Renaissance Technologies | $614,000.00 | 0.41 | 121,400 | -31.03% | -$276,249.42 | <0.01 | |
Helm Capital Management LLC | $591,377.00 | 0.4 | 116,873 | -67.02% | -$1.2M | 0.02 | |
Sio Capital Management LLC | $516,368.00 | 0.35 | 102,049 | 0% | +$0 | 0.18 | |
Eversept Partners LP | $402,715.00 | 0.27 | 79,588 | New | +$402,715.00 | 0.03 | |
Marshall Wace | $362,124.00 | 0.24 | 71,566 | New | +$362,124.00 | <0.0001 | |
State Street | $288,501.00 | 0.19 | 57,016 | +32.16% | +$70,197.39 | <0.0001 | |
BlackRock | $238,224.00 | 0.16 | 47,080 | -26.73% | -$86,925.45 | <0.0001 | |
Northern Trust | $173,685.00 | 0.12 | 34,325 | +34.01% | +$44,077.79 | <0.0001 | |
T. Rowe Price | $152,000.00 | 0.1 | 30,000 | -25% | -$50,666.67 | <0.0001 | |
Jane Street Capital | $148,349.00 | 0.1 | 29,318 | New | +$148,349.00 | <0.0001 | |
Millennium Management LLC | $131,277.00 | 0.09 | 25,944 | -24.73% | -$43,131.56 | <0.0001 | |
Woodline Partners LP | $119,644.00 | 0.08 | 23,645 | New | +$119,644.00 | <0.01 | |
Morgan Stanley | $99,313.00 | 0.07 | 19,627 | +10.54% | +$9,472.36 | <0.0001 | |
Vontobel Holding Ltd | $75,900.00 | 0.05 | 15,000 | New | +$75,900.00 | <0.01 | |
LINSCO PRIVATE LEDGER CORP | $69,676.00 | 0.05 | 13,770 | New | +$69,676.00 | <0.0001 | |
American Century Investments | $59,652.00 | 0.04 | 11,789 | New | +$59,652.00 | <0.0001 | |
LMR PARTNERS LLP | $50,600.00 | 0.03 | 10,000 | 0% | +$0 | <0.01 | |
Cresset Asset Management Llc | $50,600.00 | 0.03 | 10,000 | New | +$50,600.00 | <0.0001 | |
Acadian Asset Management | $26,000.00 | 0.02 | 5,259 | -87.43% | -$180,803.58 | <0.0001 | |
Tower Research Capital | $22,977.00 | 0.02 | 4,541 | -15.11% | -$4,088.40 | <0.0001 | |
Qube Research & Technologies | $12,534.00 | 0.01 | 2,477 | +61,825% | +$12,513.76 | <0.0001 | |
UBS | $12,640.00 | 0.01 | 2,498 | -15.29% | -$2,282.08 | <0.0001 | |
Ica Group Wealth Management Llc | $1,518.00 | <0.01 | 300 | New | +$1,518.00 | <0.0001 | |
Wells Fargo | $810.00 | <0.01 | 160 | +20.3% | +$136.69 | <0.0001 | |
Macquarie Group | $1,000.00 | <0.01 | 266 | New | +$1,000.00 | <0.0001 | |
Barclays | $0 | <0.01 | 23 | 0% | +$0 | <0.0001 |